Annovis Bio to Showcase New Alzheimer’s Study Findings at AAIC 2024

Annovis Bio (NYSE: ANVS), a late-stage biotechnology company specializing in the development of innovative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s...